Age distribution of PrEP users in France 2016-2019

The number of people getting treatment for pre-exposure prophylaxis against the human immunodeficiency viruses (HIV) in France has been rising over the years. Among those who used such a treatment with Truvada or a generic equivalent between January 2016 and June 2019, 15.1 percent were younger than 25 and 0.9 percent were older than 65 years.

Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2019, by age group

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

November 2019

Region

France

Survey time period

January 2016 to June 2019

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "HIV/AIDS in France"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.